The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Seasonal Influenza Vaccines-Global Market Insights and Sales Trends 2025

Seasonal Influenza Vaccines-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1822875

No of Pages : 125

Ask Your Query
Synopsis
Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine.
The global Seasonal Influenza Vaccines market size is expected to reach US$ 11150 million by 2029, growing at a CAGR of 6.9% from 2023 to 2029. The market is mainly driven by the significant applications of Seasonal Influenza Vaccines in various end use industries. The expanding demands from the Pediatrics, Adolescence, Adults and Elderly, are propelling Seasonal Influenza Vaccines market. Type A (H1N1), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Type A (H3N2) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Seasonal Influenza Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Seasonal Influenza Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Seasonal Influenza Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Seasonal Influenza Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Seasonal Influenza Vaccines covered in this report include GlaxoSmithKline plc, Sinovac Biotech Ltd, Changsheng Bio-Technology, Ccbio SA, Aleph Biomedical, Sanofi, Jiangsu Simcere Vaxtec Bio-pharmaceutical, Dalian Hissen Bio-pharm and Abbott Laboratories, etc.
The global Seasonal Influenza Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline plc
Sinovac Biotech Ltd
Changsheng Bio-Technology
Ccbio SA
Aleph Biomedical
Sanofi
Jiangsu Simcere Vaxtec Bio-pharmaceutical
Dalian Hissen Bio-pharm
Abbott Laboratories
Novartis International AG
AstraZeneca
EMERGEX VACCINES
SINOVAC
Merck & Co., Inc.
Pfizer Inc
Viatris Inc.
Vaxess Technologies Inc
OSIVAX
CSL Limited
EMERGENT
Global Seasonal Influenza Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Seasonal Influenza Vaccines market, Segment by Type:
Type A (H1N1)
Type A (H3N2)
Type B
Global Seasonal Influenza Vaccines market, by Application
Pediatrics
Adolescence
Adults
Elderly
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Seasonal Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Seasonal Influenza Vaccines Market Overview
1.1 Seasonal Influenza Vaccines Product Overview
1.2 Seasonal Influenza Vaccines Market Segment by Type
1.2.1 Type A (H1N1)
1.2.2 Type A (H3N2)
1.2.3 Type B
1.3 Global Seasonal Influenza Vaccines Market Size by Type
1.3.1 Global Seasonal Influenza Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Seasonal Influenza Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Seasonal Influenza Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Seasonal Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Seasonal Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Seasonal Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Seasonal Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Seasonal Influenza Vaccines Sales Breakdown by Type (2018-2023)
2 Global Seasonal Influenza Vaccines Market Competition by Company
2.1 Global Top Players by Seasonal Influenza Vaccines Sales (2018-2023)
2.2 Global Top Players by Seasonal Influenza Vaccines Revenue (2018-2023)
2.3 Global Top Players by Seasonal Influenza Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Seasonal Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Seasonal Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Seasonal Influenza Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Seasonal Influenza Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Seasonal Influenza Vaccines Market
2.8 Key Manufacturers Seasonal Influenza Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Seasonal Influenza Vaccines Status and Outlook by Region
3.1 Global Seasonal Influenza Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Seasonal Influenza Vaccines Historic Market Size by Region
3.2.1 Global Seasonal Influenza Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Seasonal Influenza Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Seasonal Influenza Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Seasonal Influenza Vaccines Forecasted Market Size by Region
3.3.1 Global Seasonal Influenza Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Seasonal Influenza Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Seasonal Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Seasonal Influenza Vaccines by Application
4.1 Seasonal Influenza Vaccines Market Segment by Application
4.1.1 Pediatrics
4.1.2 Adolescence
4.1.3 Adults
4.1.4 Elderly
4.2 Global Seasonal Influenza Vaccines Market Size by Application
4.2.1 Global Seasonal Influenza Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Seasonal Influenza Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Seasonal Influenza Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Seasonal Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Seasonal Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Seasonal Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Seasonal Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Seasonal Influenza Vaccines Sales Breakdown by Application (2018-2023)
5 North America Seasonal Influenza Vaccines by Country
5.1 North America Seasonal Influenza Vaccines Historic Market Size by Country
5.1.1 North America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Seasonal Influenza Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Seasonal Influenza Vaccines Sales in Value by Country (2018-2023)
5.2 North America Seasonal Influenza Vaccines Forecasted Market Size by Country
5.2.1 North America Seasonal Influenza Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Seasonal Influenza Vaccines Sales in Value by Country (2024-2029)
6 Europe Seasonal Influenza Vaccines by Country
6.1 Europe Seasonal Influenza Vaccines Historic Market Size by Country
6.1.1 Europe Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Seasonal Influenza Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Seasonal Influenza Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Seasonal Influenza Vaccines Forecasted Market Size by Country
6.2.1 Europe Seasonal Influenza Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Seasonal Influenza Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Seasonal Influenza Vaccines by Region
7.1 Asia-Pacific Seasonal Influenza Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Seasonal Influenza Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Seasonal Influenza Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Seasonal Influenza Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Seasonal Influenza Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Seasonal Influenza Vaccines Sales in Value by Region (2024-2029)
8 Latin America Seasonal Influenza Vaccines by Country
8.1 Latin America Seasonal Influenza Vaccines Historic Market Size by Country
8.1.1 Latin America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Seasonal Influenza Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Seasonal Influenza Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Seasonal Influenza Vaccines Forecasted Market Size by Country
8.2.1 Latin America Seasonal Influenza Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Seasonal Influenza Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Seasonal Influenza Vaccines by Country
9.1 Middle East and Africa Seasonal Influenza Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Seasonal Influenza Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Seasonal Influenza Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Seasonal Influenza Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Seasonal Influenza Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Seasonal Influenza Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline plc
10.1.1 GlaxoSmithKline plc Company Information
10.1.2 GlaxoSmithKline plc Introduction and Business Overview
10.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products Offered
10.1.5 GlaxoSmithKline plc Recent Development
10.2 Sinovac Biotech Ltd
10.2.1 Sinovac Biotech Ltd Company Information
10.2.2 Sinovac Biotech Ltd Introduction and Business Overview
10.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Products Offered
10.2.5 Sinovac Biotech Ltd Recent Development
10.3 Changsheng Bio-Technology
10.3.1 Changsheng Bio-Technology Company Information
10.3.2 Changsheng Bio-Technology Introduction and Business Overview
10.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Products Offered
10.3.5 Changsheng Bio-Technology Recent Development
10.4 Ccbio SA
10.4.1 Ccbio SA Company Information
10.4.2 Ccbio SA Introduction and Business Overview
10.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ccbio SA Seasonal Influenza Vaccines Products Offered
10.4.5 Ccbio SA Recent Development
10.5 Aleph Biomedical
10.5.1 Aleph Biomedical Company Information
10.5.2 Aleph Biomedical Introduction and Business Overview
10.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Aleph Biomedical Seasonal Influenza Vaccines Products Offered
10.5.5 Aleph Biomedical Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Information
10.6.2 Sanofi Introduction and Business Overview
10.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sanofi Seasonal Influenza Vaccines Products Offered
10.6.5 Sanofi Recent Development
10.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
10.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
10.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Introduction and Business Overview
10.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Products Offered
10.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
10.8 Dalian Hissen Bio-pharm
10.8.1 Dalian Hissen Bio-pharm Company Information
10.8.2 Dalian Hissen Bio-pharm Introduction and Business Overview
10.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Products Offered
10.8.5 Dalian Hissen Bio-pharm Recent Development
10.9 Abbott Laboratories
10.9.1 Abbott Laboratories Company Information
10.9.2 Abbott Laboratories Introduction and Business Overview
10.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Abbott Laboratories Seasonal Influenza Vaccines Products Offered
10.9.5 Abbott Laboratories Recent Development
10.10 Novartis International AG
10.10.1 Novartis International AG Company Information
10.10.2 Novartis International AG Introduction and Business Overview
10.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis International AG Seasonal Influenza Vaccines Products Offered
10.10.5 Novartis International AG Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Company Information
10.11.2 AstraZeneca Introduction and Business Overview
10.11.3 AstraZeneca Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 AstraZeneca Seasonal Influenza Vaccines Products Offered
10.11.5 AstraZeneca Recent Development
10.12 EMERGEX VACCINES
10.12.1 EMERGEX VACCINES Company Information
10.12.2 EMERGEX VACCINES Introduction and Business Overview
10.12.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 EMERGEX VACCINES Seasonal Influenza Vaccines Products Offered
10.12.5 EMERGEX VACCINES Recent Development
10.13 SINOVAC
10.13.1 SINOVAC Company Information
10.13.2 SINOVAC Introduction and Business Overview
10.13.3 SINOVAC Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 SINOVAC Seasonal Influenza Vaccines Products Offered
10.13.5 SINOVAC Recent Development
10.14 Merck & Co., Inc.
10.14.1 Merck & Co., Inc. Company Information
10.14.2 Merck & Co., Inc. Introduction and Business Overview
10.14.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Merck & Co., Inc. Seasonal Influenza Vaccines Products Offered
10.14.5 Merck & Co., Inc. Recent Development
10.15 Pfizer Inc
10.15.1 Pfizer Inc Company Information
10.15.2 Pfizer Inc Introduction and Business Overview
10.15.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Pfizer Inc Seasonal Influenza Vaccines Products Offered
10.15.5 Pfizer Inc Recent Development
10.16 Viatris Inc.
10.16.1 Viatris Inc. Company Information
10.16.2 Viatris Inc. Introduction and Business Overview
10.16.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Viatris Inc. Seasonal Influenza Vaccines Products Offered
10.16.5 Viatris Inc. Recent Development
10.17 Vaxess Technologies Inc
10.17.1 Vaxess Technologies Inc Company Information
10.17.2 Vaxess Technologies Inc Introduction and Business Overview
10.17.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Products Offered
10.17.5 Vaxess Technologies Inc Recent Development
10.18 OSIVAX
10.18.1 OSIVAX Company Information
10.18.2 OSIVAX Introduction and Business Overview
10.18.3 OSIVAX Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 OSIVAX Seasonal Influenza Vaccines Products Offered
10.18.5 OSIVAX Recent Development
10.19 CSL Limited
10.19.1 CSL Limited Company Information
10.19.2 CSL Limited Introduction and Business Overview
10.19.3 CSL Limited Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.19.4 CSL Limited Seasonal Influenza Vaccines Products Offered
10.19.5 CSL Limited Recent Development
10.20 EMERGENT
10.20.1 EMERGENT Company Information
10.20.2 EMERGENT Introduction and Business Overview
10.20.3 EMERGENT Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.20.4 EMERGENT Seasonal Influenza Vaccines Products Offered
10.20.5 EMERGENT Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Seasonal Influenza Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Seasonal Influenza Vaccines Industrial Chain Analysis
11.4 Seasonal Influenza Vaccines Market Dynamics
11.4.1 Seasonal Influenza Vaccines Industry Trends
11.4.2 Seasonal Influenza Vaccines Market Drivers
11.4.3 Seasonal Influenza Vaccines Market Challenges
11.4.4 Seasonal Influenza Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Seasonal Influenza Vaccines Distributors
12.3 Seasonal Influenza Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock